Detalles de la búsqueda
1.
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.
Oncologist
; 18(4): 439-45, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23442308
2.
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Cancer Med
; 12(10): 11525-11541, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999734
3.
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).
Sci Rep
; 11(1): 23140, 2021 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848786
4.
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).
Lung Cancer
; 156: 12-19, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872943
5.
Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer.
Cancer Sci
; 99(2): 361-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18201271
6.
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Int J Radiat Oncol Biol Phys
; 70(2): 374-81, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18029106
7.
HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells.
Mol Cancer Res
; 2(5): 305-14, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15192124
8.
Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy.
Int J Clin Oncol
; 14(2): 125-9, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19390943
9.
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Cancer Immunol Immunother
; 57(2): 165-74, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17628800
10.
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.
J Clin Oncol
; 26(33): 5401-6, 2008 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18854562
11.
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Cancer Sci
; 98(9): 1424-30, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17645781
12.
Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells.
J Biol Chem
; 280(17): 16728-38, 2005 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15737994
13.
RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung.
Oncology
; 62(4): 333-9, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12138241
14.
CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.
Cancer Sci
; 94(11): 1003-9, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14611679
15.
Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas.
Cancer
; 94(3): 752-8, 2002 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11857309
Resultados
1 -
15
de 15
1
Próxima >
>>